Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2019

Open Access 01-12-2019 | Thoracic Tumor | Research

Comparison of the dose on specific 3DCT images and the accumulated dose for cardiac structures in esophageal tumors radiotherapy: whether specific 3DCT images can be used for dose assessment?

Authors: Ying Tong, Guanzhong Gong, Ming Su, Yong Yin

Published in: Radiation Oncology | Issue 1/2019

Login to get access

Abstract

Background

Cardiac activity could impact the accuracy of dose assessment for the heart, pericardium and left ventricular myocardium (LVM). The purpose of this study was to explore whether it is possible to perform dose assessment by contouring the cardiac structures on specific three-dimensional computed tomography (3DCT) images to reduce the impact of cardiac activity.

Methods

Electrocardiograph-gated 4DCT (ECG-gated 4DCT) images of 22 patients in breath-hold were collected. MIM Maestro 6.8.2 (MIM) was used to reconstruct specific 3DCT images to obtain the Maximal intensity projection (MIP) image, Average intensity projection (AIP) image and Minimum intensity projection (Min-IP) image. The heart, pericardium and LVM were contoured in 20 phases of 4DCT images (0, 5%... 95%) and the MIP, AIP and Min-IP images. Then, a radiotherapy plan was designed at the 0% phase of the 4DCT images, and the dose was transplanted to all phases of 4DCT to acquire the dose on all phases, the accumulated dose of all phases was calculated using MIM. The dose on MIP, AIP and Min-IP images were also obtained by deformable registration of the dose. The mean dose (Dmean), V5, V10, V20, V30 and V40 for the heart, pericardium and LVM in MIP, AIP and Min-IP images were compared with the corresponding parameters after dose accumulation.

Results

The mean values of the difference between the Dmean in the MIP image and the Dmean after accumulation for the heart, pericardium and LVM were all less than 1.50 Gy, and the dose difference for the pericardium and LVM was not statistically significant (p > 0.05). For dose-volume parameters, there was no statistically significant difference between V5, V10, and V20 of the heart and pericardium in MIP, AIP, and Min-IP images and those after accumulation (p > 0.05). For the LVM, only in the MIP image, the differences of V5, V10, V20, V30 and V40 were not significant compared to those after dose accumulation (p > 0.05).

Conclusions

There was a smallest difference for the dosimetry parameters of cardiac structures on MIP image compared to corresponding parameters after dose accumulation. Therefore, it is recommended to use the MIP image for the delineation and dose assessment of cardiac structures in clinical practice.
Literature
1.
Taylor CW, Brønnum D, Darby SC, et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001[J]. Radiother Oncol. 2011;100(2):176–83.CrossRef
2.
Joseph N, Mcwilliam A, Kennedy J, et al. Post-treatment lymphocytopenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy[J]. Radiother Oncol. 2019;135:115–9.CrossRef
3.
Zhu Q, Kirova YM, Cao L, et al. Cardiotoxicity associated with radiotherapy in breast cancer: a question-based review with current literatures[J]. Cancer Treat Rev. 2018;68:9–15.CrossRef
4.
Kole TP, Aghayere O, Kwah J, et al. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer[J]. Int J Radiat Oncol Biol Phys. 2012;83:1580–6.CrossRef
5.
Madan R, Benson R, Sharma DN, et al. Radiation induced heart disease: pathogenesis, management and review literature[J]. J Egypt Natl Canc Inst. 2015;27(4):187–93.CrossRef
6.
Duane FK, McGale P, Brønnum D, et al. Cardiac structure doses in women irradiated for breast Cancer in the past and their use in epidemiological studies[J]. Pract Radiat Oncol. 2019;9(3):158–71.CrossRef
7.
Evans ES, Prosnitz RG, Yu X, et al. Impact of patient-specifc factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer[J]. Int J Radiat Oncol Biol Phys. 2006;66(4):1125–34.CrossRef
8.
Mast ME, Van Kempen-Harteveld L, Heijenbrok MW, et al. Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further? [J]. Radiother Oncol. 2013;108(2):248–53.CrossRef
9.
Shah C, Badiyan S, Berry S, et al. Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy[J]. Radiother Oncol. 2014;112(1):9–16.CrossRef
10.
Kataria T, Bisht SS, Gupta D, et al. Quantification of coronary artery motion and internal risk volume from ECG gated radiotherapy planning scans[J]. Radiother Oncol. 2016;121:59–63.CrossRef
11.
Lee S, Zheng Y, Podder T, et al. Tumor localization accuracy for high-precision radiotherapy during active breath-hold[J]. Radiother Oncol. 2019;137:145–52.CrossRef
12.
Ledsom D, Reilly AJ, Probst H. Assessment of deep inspiration breath hold (DIBH) amplitude and reduction in cardiac dose in left breast cancer patients[J]. Radiogr (Lond). 2018;24(2):98–103.CrossRef
13.
Nissen HD, Appelt AL. Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients[J]. Radiother Oncol. 2013;106(1):28–32.CrossRef
14.
Ying T, Yong Y, Pinjing C, et al. Quantification of variation in dose–volume parameters for the heart, pericardium and left ventricular myocardium during thoracic tumor radiotherapy[J]. J Radiat Res. 2018;59(4):462–8.CrossRef
15.
Ying T, Yong Y, Jie L, et al. Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy[J]. Onco Targets Ther. 2018;11:547–54.CrossRef
16.
Piper J. Evaluation of an intensity-based free-form deformable registration algorithm[J]. Med Phys. 2007;34:2353–4.CrossRef
17.
Jang SS, Huh GJ, Park SY, et al. The impact of respiratory gating on lung dosimetry in stereotactic body radiotherapy for lung cancer[J]. Phys Med. 2014;30(6):682–9.CrossRef
18.
Shimizu S, Shirato H, Kagei K, et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy[J]. Int J Radiat Oncol Biol Phys. 2000;46(5):1127–33.CrossRef
19.
Giraud P, Morvan E, Claude L, et al. Respiratory gating techniques for optimization of lung Cancer radiotherapy[J]. J Thorac Oncol. 2011;6(12):2058–68.CrossRef
20.
Simonetto C, Eidemüller M, Gaasch A, et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy[J]. Radiother Oncol. 2019;131(2):202–7.CrossRef
21.
Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer[J]. Int J Radiat Oncol Biol Phys. 2005;63(1):253–60.CrossRef
22.
Muirhead R, Mcnee SG, Featherstone C, et al. Use of maximum intensity projections (MIPs) for target outlining in 4DCT radiotherapy planning[J]. J Thorac Oncol. 2008;3(12):1433–8.CrossRef
Metadata
Title
Comparison of the dose on specific 3DCT images and the accumulated dose for cardiac structures in esophageal tumors radiotherapy: whether specific 3DCT images can be used for dose assessment?
Authors
Ying Tong
Guanzhong Gong
Ming Su
Yong Yin
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2019
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-019-1450-6

Other articles of this Issue 1/2019

Radiation Oncology 1/2019 Go to the issue

Research

Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy

Review

The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer

Research

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

Research

RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies

Research

Ionizing radiation and bone quality: time-dependent effects

Research

Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines